Kazuo Miyashita Selected Research

fucoxanthinol

1/2022	A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
5/2021	Fucoxanthin and Colorectal Cancer Prevention.
5/2021	Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from an N-Nitrosobis(2-oxopropyl)amine-initiated Syrian Golden Hamster Pancreatic Carcinogenesis Model.
3/2021	A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell.
1/2021	Effects of CLIC4 on Fucoxanthinol-Induced Apoptosis in Human Colorectal Cancer Cells.
4/2020	Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes.
1/2019	Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice.
1/2019	Fucoxanthin administration delays occurrence of tumors in xenograft mice by colonospheres, with an anti-tumor predictor of glycine.
7/2018	Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
1/2018	Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuo Miyashita Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 02/2002
12	Obesity 03/2020 - 07/2002
11	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 09/2015
10	Body Weight (Weight, Body) 01/2019 - 02/2002
9	Colonic Neoplasms (Colon Cancer) 01/2022 - 07/2004
8	Carcinogenesis 01/2022 - 06/2004
8	Inflammation (Inflammations) 01/2021 - 10/2005
5	Adenocarcinoma 01/2022 - 08/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2011
5	Insulin Resistance 01/2020 - 12/2004
5	Weight Gain 08/2015 - 09/2007
5	Aberrant Crypt Foci 01/2007 - 02/2002
4	Hyperglycemia 06/2012 - 12/2004
3	Hepatocellular Carcinoma (Hepatoma) 02/2014 - 03/2005
3	Hyperinsulinism (Hyperinsulinemia) 06/2012 - 12/2004
2	Hypoxia (Hypoxemia) 01/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 07/2017 - 12/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2017 - 03/2002
2	Leukemia 07/2008 - 01/2006
2	Fatty Liver 06/2007 - 12/2004
1	Muscular Atrophy (Muscle Atrophy) 03/2021
1	Atrophy 04/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019
1	Polyps 03/2019
1	Atherosclerosis 09/2012
1	Colitis 08/2011

Drug/Important Bio-Agent (IBA)

37	fucoxanthinIBA 01/2022 - 11/2004
18	fucoxanthinolIBA 01/2022 - 01/2006
15	Carotenoids (Carotene)IBA 01/2022 - 11/2004
10	AzoxymethaneIBA 01/2022 - 02/2002
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
6	LipidsIBA 03/2020 - 06/2004
5	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2020 - 01/2018
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011 - 12/2004
5	alpha-Linolenic Acid (Linolenic Acid)IBA 11/2006 - 02/2002
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 12/2019
4	Blood Glucose (Blood Sugar)IBA 01/2012 - 09/2007
4	Conjugated Linoleic AcidsIBA 01/2007 - 06/2004
4	PPAR gammaIBA 08/2005 - 06/2004
3	Dextrans (Dextran)FDA Link 01/2022 - 11/2020
3	Triglycerides (Triacylglycerol)IBA 04/2020 - 12/2004
3	Biological ProductsIBA 01/2020 - 08/2011
3	Messenger RNA (mRNA)IBA 01/2020 - 12/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2011 - 07/2002
2	CC ChemokinesIBA 01/2022 - 12/2021
2	XanthophyllsIBA 01/2022 - 10/2017
2	LigandsIBA 12/2021 - 11/2004
2	SuspensionsIBA 01/2021 - 01/2019
2	Dextran SulfateIBA 01/2021 - 08/2011
2	Indicators and Reagents (Reagents)IBA 11/2020 - 05/2006
2	CaspasesIBA 10/2017 - 12/2013
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2017 - 02/2014
2	Insulin (Novolin)FDA Link 05/2013 - 03/2012
2	LeptinIBA 05/2013 - 12/2004
2	Fish OilsIBA 06/2012 - 09/2007
2	CytokinesIBA 08/2011 - 05/2011
2	AntioxidantsIBA 08/2011 - 01/2009
2	Linolenic AcidsIBA 01/2011 - 05/2006
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011 - 06/2004
2	AdipokinesIBA 12/2010 - 12/2004
2	Linoleic Acid (Linoleate)IBA 01/2007 - 03/2005
1	Cadherins (E-Cadherin)IBA 12/2021
1	Chemokine CCL21IBA 12/2021
1	Small Interfering RNA (siRNA)IBA 12/2021
1	nitrosobis(2-oxopropyl)amine (NBOP)IBA 05/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2021
1	Epoxy Compounds (Epoxides)IBA 01/2021
1	ChloridesIBA 01/2021
1	Sucrose (Saccharose)IBA 03/2020
1	Chloroform (Trichloromethane)IBA 03/2020
1	Methanol (Carbinol)IBA 03/2020
1	Ethanol (Ethyl Alcohol)IBA 03/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	IntegrinsIBA 12/2019
1	PhosphatidylglycerolsIBA 11/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2019
1	Cyclin D1IBA 01/2019
1	Succinic Acid (Succinate)IBA 07/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2015
1	Fluorouracil (Carac)FDA LinkGeneric 09/2015
1	Pharmaceutical PreparationsIBA 09/2015
1	CollagenIBA 09/2015
1	CholesterolIBA 09/2012
1	Taurine FDA Link 06/2012
1	Caffeine (No Doz)FDA LinkGeneric 01/2012
1	Capsaicin (Zostrix)FDA Link 01/2012
1	Food IngredientsIBA 01/2012
1	Epstein-Barr virus early antigenIBA 10/2011
1	anthraceneIBA 10/2011
1	InterleukinsIBA 08/2011
1	astaxanthine (astaxanthin)IBA 08/2011
1	Hydroxyl RadicalIBA 05/2011

Therapy/Procedure

4	Subcutaneous Injections 11/2006 - 02/2002
3	Chemoprevention 01/2022 - 10/2017
2	Oral Administration 03/2021 - 01/2021
1	Transplantation 12/2021
1	Drug Therapy (Chemotherapy) 05/2021
1	Therapeutics 05/2011